While COVID-19 has highlighted the invaluable nature of medical research, it has unfortunately also seriously disrupted it. In Australia, the sector now teeters on the brink of collapse.
People wearing masks walk in front of Pfizer’s headquarters in New York City. Pfizer and BioNtech are on track with a vaccine that is 90 per cent effective, say preliminary results, but they are not the only ones in the race.
AP Photo/Bebeto Matthews
Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Light is key to ultrasensitive chemical sensors.
Kwanchai Lerttanapunyaporn/EyeEm via Getty Images
An optical sensor that can detect individual molecules promises early detection of diseases and environmental contamination.
An artificial respirator made by Both Equipment Ltd, Adelaide, South Australia, 1950-1959.
Drawing thoughtfully on the Powerhouse Museum's collection, this exhibition lovingly exposes the humanity behind biomedical technology.
Duck decoys lure real ducks within range of hunters. Nanoparticles that look like cells serve as both decoys and hunters to ensnare virus particles.
Nanoparticles dressed up in cell membranes snag SARS-CoV-2 virus particles before they reach human cells.
A cutting edge new research project is developing Lego-like bricks made from biomaterials to replace bone fragments in shattered limbs.
Artificial intelligence can do what humans can’t – connect the dots across the majority of coronavirus research.
baranozdemir/E+ via Getty Images
The scientific community is churning out vast quantities of research about the coronavirus pandemic – far too much for researchers to absorb. An AI system aims to do the heavy lifting for them.
A number of young COVID-19 patients have developed inflammation in multiple organs.
Ezra Acayan/Getty Images
A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.
Traditional approaches to biomedical research and development are costly and time consuming.
Crowdsourcing is a promising approach to biomedical research and development (R&D) and could produce solutions to pandemics like this one.
Monaco and Japan have some of the highest life expectancies in the world. But calculating an individual’s life expectancy will require taking data analysis several steps further.
Predicting life expectancy remains in the realm of science fiction, but it may soon be possible. Are we prepared for such information? And who else would benefit from this knowledge?
A few woefully underfunded academic health sciences centres are responsible for providing complex care to patients with life-threatening illnesses as well as training future doctors and testing the latest in new surgical techniques.
Canada's systems of health funding, medical training and physician compensation need an overhaul – to support vital centres of medical research and complex care.
It takes time to see which finding might be a golden egg.
Basic research can be easy to mock as pointless and wasteful of resources. But it's very often the foundation for future innovation – even in ways the original scientists couldn't have imagined.
It may take time for a tiny step forward to show its worth.
Scientists are rewarded with funding and publications when they come up with innovative findings. But in the midst of a 'reproducibility crisis,' being new isn't the only thing to value about research.
Kaylee Wedderburn-Pugh, a SPURS student, working to help find answers to Huntington’s disease.
Affirmative action programs at universities are under threat by the Trump administration. That could be especially damaging to medical education. Who knows who holds the idea for the next great cure?
Are research nonprofits holding up their end of the tax-exempt bargain?
Holding patents can be a lucrative and powerful position to be in. Here's a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
President Barack Obama signs the 21st Century Cures Act on Tuesday, Dec. 13, 2016, in Washington.
Kevin Wolf/AP Images for Parker Foundation
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
Obama annually welcomed students to the White House with their Science Fair projects.
AP Photo/Susan Walsh
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
More is less in the world of research publications.
Desktop image via www.shutterstock.com.
The traditional mode of publishing scientific research faces much criticism – primarily for being too slow and sometimes shoddily done. Maybe fewer publications of higher quality is the way forward.
Who are the winners and losers from recent medical research funding announcements?
The recent NHMRC funding announcement has renewed criticism about how medical research is funded in Australia. Is the system fair? Or is it stacked against some researchers?
Will China be the first to genetically enhance future generations?
Regulations, funding and public opinion around genetically enhancing future generations vary from country to country. Here's why China may be poised to be the pioneer.